Skip to content

Itrevia 5 HF-T QP DF4 IS4 402659Recalls & reported problems

BIOTRONIK SE & Co. KG · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04035479140144), received between Jul 7, 2021 and Jul 7, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Elective Replacement Indicator” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Premature Elective Replacement Indicator1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 7, 2021Premature Elective Replacement Indicator; Premature Elective Replacement Indicator

    IT WAS REPORTED THAT THE DEVICE REACHED ERI STATUS APPROX. 44 MONTHS AFTER THE IMPLANTATION. PLEASE NOTE THIS ICD IS AFFECTED BY A FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN (B)(6) 2021 AND THE AWARENESS DATE OF THE EVENT WAS BEFORE THE FSCA STARTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12129986 ↗

Other Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices

All Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page